Critical Vasospasm During Fingolimod (FTY720) Treatment in a Patient with Multiple Sclerosis
Authors
Affiliations
Treatment-Related Reversible Cerebral Vasoconstriction Syndrome.
Avola G, Pezzini A J Clin Med. 2024; 13(19).
PMID: 39407990 PMC: 11478140. DOI: 10.3390/jcm13195930.
Livedo Reticularis in Association with Fingolimod: A Case Report.
Afacan Yildirim E, Adisen E Indian J Dermatol. 2024; 69(1):97-99.
PMID: 38572037 PMC: 10986891. DOI: 10.4103/ijd.ijd_800_23.
Mechanism and adverse effects of multiple sclerosis drugs: a review article. Part 1.
Rafiee Zadeh A, Askari M, Azadani N, Ataei A, Ghadimi K, Tavoosi N Int J Physiol Pathophysiol Pharmacol. 2019; 11(4):95-104.
PMID: 31523357 PMC: 6737429.
Non-traumatic Acute Epidural Hematoma in Multiple Sclerosis Treated With Fingolimod.
Fukai R, Takahashi K, Abe H, Higashiyama Y, Doi H, Takeuchi H Front Neurol. 2019; 10:763.
PMID: 31379717 PMC: 6659100. DOI: 10.3389/fneur.2019.00763.
Fingolimod: therapeutic mechanisms and ocular adverse effects.
Mandal P, Gupta A, Fusi-Rubiano W, Keane P, Yang Y Eye (Lond). 2016; 31(2):232-240.
PMID: 27886183 PMC: 5306460. DOI: 10.1038/eye.2016.258.